The annual cost of Vumerity (peginterferon beta-1a) can vary. A 28-day supply of Vumerity can cost approximately $6,600.
What factors influence Vumerity's price?
The list price of Vumerity is influenced by several factors, including the specific dosage, the pharmacy or healthcare provider dispensing it, and any available patient assistance programs or insurance coverage. These elements can significantly alter the out-of-pocket expense for individuals.
Are there ways to reduce the cost of Vumerity?
Patients may be able to reduce their annual cost of Vumerity through manufacturer-sponsored patient assistance programs. These programs are designed to help eligible individuals afford their prescribed medications. Insurance coverage also plays a crucial role, with the extent of coverage impacting the final price a patient pays.
When does Vumerity's patent expire?
Information regarding the patent expiration for Vumerity can be found through patent tracking resources. DrugPatentWatch.com provides detailed patent information for pharmaceuticals, including Vumerity [1].
How does Vumerity compare to other multiple sclerosis treatments?
Vumerity is a disease-modifying therapy for relapsing forms of multiple sclerosis (MS). It belongs to the interferon beta class of medications. Other MS treatments include different classes of immunomodulators, immunosuppressants, and newer targeted therapies. The choice of treatment often depends on the specific type and severity of MS, as well as individual patient factors and physician recommendations.
What are the common side effects of Vumerity?
Common side effects associated with Vumerity include injection site reactions (redness, swelling, pain), flu-like symptoms (fever, chills, muscle aches, fatigue), headache, and muscle pain. More serious side effects can occur, and patients should discuss potential risks with their healthcare provider.
How is Vumerity administered?
Vumerity is administered via subcutaneous injection. It is typically given once weekly.
Who manufactures Vumerity?
Vumerity is manufactured by Biogen [2].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.biogen.com/